J Korean Med Sci.  1998 Feb;13(1):31-38. 10.3346/jkms.1998.13.1.31.

Pathologic characteristics of primary cutaneous T-cell lymphoma in Korea

Affiliations
  • 1Department of Pathology, Seoul National University College of Medicine, Korea.

Abstract

Cutaneous T-cell lymphomas (CTCL) represent a heterogeneous group of peripheral T-cell lymphomas arising in the skin and show considerable variations in clinicopathological features. This study was designed to examine viral genomes and cellular proliferation markers in CTCLs arising in Korea. On the basis of their morphologic characteristics and immunophenotypes, 43 cases of primary CTCL were classified, and evaluated for association with either HTLV-I or EBV, p53 protein immunoreactivity and Ki-67 labeling index (LI). EBV was demonstrated in 15 cases (35%) either by EBER in-situ hybridization or PCR; particularly high rates were exhibited by angiocentric T-cell lymphomas. PCR was used to detect HTLV-I proviral DNA, but none was found. The p53 expression rate was higher in large cell lesions, but the Ki-67 LI failed to show any significant differences among the different types. We therefore concluded that in Korea, HTLV-I is less frequently associated with CTCL than in other endemic countries. EBV was found particularly in angiocentric lesions, regardless of cell size or degree of pleomorphism. Because of its high positive rates in high grade lesions, the p53 expression showed positive correlation with histologic grade; however, the Ki-67 labeling index did not correlate with the histologic grade in CTCL.


MeSH Terms

Adolescence
Adult
Aged
Aged, 80 and over
Child
Female
HTLV-I/genetics
Herpesvirus 4, Human/genetics
Human
Korea
Lymphoma, Large-Cell, Ki-1/pathology
Lymphoma, T-Cell, Cutaneous/virology
Lymphoma, T-Cell, Cutaneous/pathology*
Male
Middle Age
Mycosis Fungoides/pathology
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr